Tag: constipation treatment market trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Larger Will The Constipation Treatment Market Become By 2030 Compared To 2026?

The constipation treatment market has seen substantial growth over recent years. It is forecast to increase from $12.71 billion in 2025 to $13.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. This historical expansion can be linked to the high prevalence of gastrointestinal disorders, sedentary lifestyle patterns, dietary fiber deficiency, reliance on traditional laxatives, and the growth of the aging population.

The constipation treatment market is projected for significant expansion over the coming years, anticipated to reach $18.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. This anticipated growth is largely driven by factors such as an increase in chronic constipation diagnoses, elevated opioid consumption, a heightened focus on gut health, the expansion of specialized gastroenterology services, and better availability of new therapeutic options. Key trends expected during this period involve a surge in prescribed treatments for chronic constipation, greater uptake of probiotics and related gut health items, a move towards drugs with specific mechanisms of action, an intensified effort in managing opioid-induced constipation, and the broadening reach of online pharmacy distribution.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12134&type=smp

Which Major Factors Are Contributing To The Development Of The Constipation Treatment Market?

An anticipated surge in gastrointestinal disorders is set to propel the expansion of the constipation treatment market in the foreseeable future. Digestive disorders, also known as gastrointestinal disorders, cover a variety of ailments impacting the digestive tract, and constipation frequently manifests as a symptom of many of these conditions. The rising occurrence of gastrointestinal disorders, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), stimulates the growth of the constipation treatment market because these ailments often present with constipation, leading to a greater demand for targeted and efficacious treatments amidst increasing understanding. For example, the American Cancer Society, a non-profit organization located in the U.S., projected in January 2024 that around 26,890 new instances of stomach cancer would be expected in the U.S. in 2024, with 16,160 cases among men and 10,730 among women. This form of cancer is also expected to result in approximately 10,880 fatalities, split between 6,490 men and 4,390 women. Consequently, the increasing prevalence of gastrointestinal disorders is a key factor driving the growth of the constipation treatment market.

Which Segment Groups Define The Constipation Treatment Market Landscape?

The constipation treatment market covered in this report is segmented –

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Therapeutics

2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

2) By Chloride Channel Activators: Lubiprostone-Based Formulations, Other Chloride Channel Activators

3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone Formulations, Naloxegol Formulations, Other PAMORAs

4) By Guanylate Cyclase-C (GC-C) Agonists: Linaclotide Formulations, Plecanatide Formulations, Other GC-C Agonists

5) By Other Therapeutics: Prokinetic Agents, Serotonin 5-HT4 Receptor Agonists, Herbal and Alternative Formulations

What Trends Are Influencing The Future Of The Constipation Treatment Market?

Leading companies in the constipation treatment market are concentrating on creating novel remedies, such as drug-free mechanical stimulation capsules (vibrating capsules). This effort aims to satisfy the increasing need for efficacious therapies that minimize side effects, a demand fueled by an aging demographic, increased opioid consumption, and patients’ preference for non-pharmacological approaches. Such a vibrating capsule is a single-use oral device designed for swallowing. It encases a miniature vibration motor and battery within a medical-grade, excretable shell. Its purpose is to mechanically stimulate the colon at predetermined intervals, thereby inducing peristalsis and providing predictable bowel movements without the systemic impacts typically associated with laxatives or prescription prokinetics. As an illustration, in May 2023, Vibrant Ltd., a medical technology firm based in the US, introduced Vibrant. This prescription-only vibrating capsule system received clearance from the U.S. Food and Drug Administration (FDA) for use by adults suffering from chronic idiopathic constipation who have shown no improvement with laxatives. The system comprises a reusable activation pod and a single-use capsule. This capsule contains a coin-sized vibration motor, an electronic control card, and batteries, all contained within a two-piece shell. The pod is responsible for programming the capsule, which subsequently delivers a sequence of brief vibration cycles, specifically around 190 cycles per hour, featuring timed bursts and rests, all engineered to encourage colonic contractions.

Who Are The Major Companies Operating In The Constipation Treatment Market?

Major companies operating in the constipation treatment market are Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, Allergan plc

Access The Complete Constipation Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

What Is The Largest Regional Market In The Constipation Treatment Market?

North America was the largest region in the constipation treatment market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Constipation Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12134&type=smp

Browse Through More Reports Similar to the Global Constipation Treatment Market 2026, By The Business Research Company

Connected Health And Wellness Solutions Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/connected-health-and-wellness-solutions-global-market-report

Healthcare Services Market 2026

https://www.thebusinessresearchcompany.com/report/healthcare-services-market

Healthcare Services Market 2026

https://www.thebusinessresearchcompany.com/report/healthcare-services-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Constipation Treatment Market Between 2026 And 2030?

The constipation treatment market has experienced significant expansion in recent years. It is anticipated to grow from $12.71 billion in 2025 to $13.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. This historical growth can be ascribed to a high prevalence of gastrointestinal disorders, sedentary lifestyle patterns, dietary fiber deficiency, continued reliance on traditional laxatives, and the increasing aging population.

The constipation treatment market size is projected to experience substantial expansion over the upcoming years, reaching a size of $18.72 billion by 2030, driven by an 8.0% compound annual growth rate (CAGR). This anticipated growth during the forecast period is fueled by several factors such as an increase in chronic constipation diagnoses, greater reliance on opioid medications, heightened public understanding of gut health, the spread of specialized gastroenterology services, and better availability of new treatments. Key developments expected in this period encompass the increasing prescription of therapies for chronic constipation, the rising popularity of probiotics and gut health items, a move towards drugs with specific mechanisms of action, a greater emphasis on managing opioid-induced constipation, and the expansion of online pharmacy channels.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Which Key Factors Are Driving The Constipation Treatment Market Growth?

The increasing prevalence of gastrointestinal disorders is anticipated to boost the expansion of the constipation treatment market in the future. These conditions, often termed digestive disorders, encompass various ailments affecting the digestive tract, with constipation being a common symptom of many gastrointestinal (GI) disorders. The rising incidence of gastrointestinal disorders, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), drives the growth of the constipation treatment market because these conditions frequently involve constipation, thereby creating a heightened necessity for specific and effective treatments amid growing public awareness. For example, in January 2024, the American Cancer Society, a US-based non-profit organization, estimated roughly 26,890 new cases of stomach cancer in the U.S. in 2024, consisting of 16,160 cases in men and 10,730 in women. This type of cancer is also expected to result in about 10,880 fatalities, involving 6,490 men and 4,390 women. Therefore, the growing occurrence of gastrointestinal disorders is propelling the constipation treatment market’s growth.

How Are Segments Identified Within The Constipation Treatment Market Segment Framework?

The constipation treatment market covered in this report is segmented –

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Therapeutics

2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

2) By Chloride Channel Activators: Lubiprostone-Based Formulations, Other Chloride Channel Activators

3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone Formulations, Naloxegol Formulations, Other PAMORAs

4) By Guanylate Cyclase-C (GC-C) Agonists: Linaclotide Formulations, Plecanatide Formulations, Other GC-C Agonists

5) By Other Therapeutics: Prokinetic Agents, Serotonin 5-HT4 Receptor Agonists, Herbal and Alternative Formulations

Which Trends Are Guiding The Direction Of The Constipation Treatment Market?

Major companies operating in the constipation treatment market are prioritizing the development of innovative solutions, such as drug-free mechanical stimulation capsules (vibrating capsules), to meet the rising demand for effective, side-effect-sparing therapies. This demand is propelled by an aging population, increased opioid use, and patients’ inclination towards non-pharmacologic choices. A vibrating capsule represents a swallowable, single-use oral device, encompassing a small vibration motor and battery within a medical-grade, excretable shell; its purpose is to mechanically stimulate the colon at programmed times to induce peristalsis, thereby offering predictable bowel movements without the systemic effects associated with laxatives or prescription prokinetics. As an illustration, in May 2023, Vibrant Ltd., a US-based medical technology company, launched Vibrant, a prescription-only vibrating capsule system that received clearance from the U.S. Food and Drug Administration (FDA) for adults with chronic idiopathic constipation who have not responded to laxatives. The system comprises a reusable activation pod and a single-use capsule containing a coin-sized vibration motor, an electronic control card, and batteries, all encased in a two-piece shell. The pod programs the capsule, which subsequently delivers a sequence of short vibration cycles, approximately 190 cycles per hour, featuring timed bursts and rests, specifically engineered to stimulate colonic contractions.

Who Are The Companies Competing Within The Constipation Treatment Market?

Major companies operating in the constipation treatment market are Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, Allergan plc

Get The Full Constipation Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Where Is The Constipation Treatment Market Primarily Concentrated By Region?

North America was the largest region in the constipation treatment market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Constipation Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Browse Through More Reports Similar to the Global Constipation Treatment Market 2026, By The Business Research Company

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Constipation Laxative Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-laxative-global-market-report

Opioid Induced Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-induced-constipation-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Constipation Treatment Market Between 2026 And 2030?

The constipation treatment market has experienced significant expansion in recent years. It is anticipated to grow from $12.71 billion in 2025 to $13.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. This historical growth can be ascribed to a high prevalence of gastrointestinal disorders, sedentary lifestyle patterns, dietary fiber deficiency, continued reliance on traditional laxatives, and the increasing aging population.

The constipation treatment market size is projected to experience substantial expansion over the upcoming years, reaching a size of $18.72 billion by 2030, driven by an 8.0% compound annual growth rate (CAGR). This anticipated growth during the forecast period is fueled by several factors such as an increase in chronic constipation diagnoses, greater reliance on opioid medications, heightened public understanding of gut health, the spread of specialized gastroenterology services, and better availability of new treatments. Key developments expected in this period encompass the increasing prescription of therapies for chronic constipation, the rising popularity of probiotics and gut health items, a move towards drugs with specific mechanisms of action, a greater emphasis on managing opioid-induced constipation, and the expansion of online pharmacy channels.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Which Key Factors Are Driving The Constipation Treatment Market Growth?

The increasing prevalence of gastrointestinal disorders is anticipated to boost the expansion of the constipation treatment market in the future. These conditions, often termed digestive disorders, encompass various ailments affecting the digestive tract, with constipation being a common symptom of many gastrointestinal (GI) disorders. The rising incidence of gastrointestinal disorders, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), drives the growth of the constipation treatment market because these conditions frequently involve constipation, thereby creating a heightened necessity for specific and effective treatments amid growing public awareness. For example, in January 2024, the American Cancer Society, a US-based non-profit organization, estimated roughly 26,890 new cases of stomach cancer in the U.S. in 2024, consisting of 16,160 cases in men and 10,730 in women. This type of cancer is also expected to result in about 10,880 fatalities, involving 6,490 men and 4,390 women. Therefore, the growing occurrence of gastrointestinal disorders is propelling the constipation treatment market’s growth.

How Are Segments Identified Within The Constipation Treatment Market Segment Framework?

The constipation treatment market covered in this report is segmented –

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Therapeutics

2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

2) By Chloride Channel Activators: Lubiprostone-Based Formulations, Other Chloride Channel Activators

3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone Formulations, Naloxegol Formulations, Other PAMORAs

4) By Guanylate Cyclase-C (GC-C) Agonists: Linaclotide Formulations, Plecanatide Formulations, Other GC-C Agonists

5) By Other Therapeutics: Prokinetic Agents, Serotonin 5-HT4 Receptor Agonists, Herbal and Alternative Formulations

Which Trends Are Guiding The Direction Of The Constipation Treatment Market?

Major companies operating in the constipation treatment market are prioritizing the development of innovative solutions, such as drug-free mechanical stimulation capsules (vibrating capsules), to meet the rising demand for effective, side-effect-sparing therapies. This demand is propelled by an aging population, increased opioid use, and patients’ inclination towards non-pharmacologic choices. A vibrating capsule represents a swallowable, single-use oral device, encompassing a small vibration motor and battery within a medical-grade, excretable shell; its purpose is to mechanically stimulate the colon at programmed times to induce peristalsis, thereby offering predictable bowel movements without the systemic effects associated with laxatives or prescription prokinetics. As an illustration, in May 2023, Vibrant Ltd., a US-based medical technology company, launched Vibrant, a prescription-only vibrating capsule system that received clearance from the U.S. Food and Drug Administration (FDA) for adults with chronic idiopathic constipation who have not responded to laxatives. The system comprises a reusable activation pod and a single-use capsule containing a coin-sized vibration motor, an electronic control card, and batteries, all encased in a two-piece shell. The pod programs the capsule, which subsequently delivers a sequence of short vibration cycles, approximately 190 cycles per hour, featuring timed bursts and rests, specifically engineered to stimulate colonic contractions.

Who Are The Companies Competing Within The Constipation Treatment Market?

Major companies operating in the constipation treatment market are Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, Allergan plc

Get The Full Constipation Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Where Is The Constipation Treatment Market Primarily Concentrated By Region?

North America was the largest region in the constipation treatment market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Constipation Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Browse Through More Reports Similar to the Global Constipation Treatment Market 2026, By The Business Research Company

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Constipation Laxative Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-laxative-global-market-report

Opioid Induced Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-induced-constipation-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Constipation Treatment Market Between 2026 And 2030?

The constipation treatment market has experienced significant expansion in recent years. It is anticipated to grow from $12.71 billion in 2025 to $13.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. This historical growth can be ascribed to a high prevalence of gastrointestinal disorders, sedentary lifestyle patterns, dietary fiber deficiency, continued reliance on traditional laxatives, and the increasing aging population.

The constipation treatment market size is projected to experience substantial expansion over the upcoming years, reaching a size of $18.72 billion by 2030, driven by an 8.0% compound annual growth rate (CAGR). This anticipated growth during the forecast period is fueled by several factors such as an increase in chronic constipation diagnoses, greater reliance on opioid medications, heightened public understanding of gut health, the spread of specialized gastroenterology services, and better availability of new treatments. Key developments expected in this period encompass the increasing prescription of therapies for chronic constipation, the rising popularity of probiotics and gut health items, a move towards drugs with specific mechanisms of action, a greater emphasis on managing opioid-induced constipation, and the expansion of online pharmacy channels.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Which Key Factors Are Driving The Constipation Treatment Market Growth?

The increasing prevalence of gastrointestinal disorders is anticipated to boost the expansion of the constipation treatment market in the future. These conditions, often termed digestive disorders, encompass various ailments affecting the digestive tract, with constipation being a common symptom of many gastrointestinal (GI) disorders. The rising incidence of gastrointestinal disorders, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), drives the growth of the constipation treatment market because these conditions frequently involve constipation, thereby creating a heightened necessity for specific and effective treatments amid growing public awareness. For example, in January 2024, the American Cancer Society, a US-based non-profit organization, estimated roughly 26,890 new cases of stomach cancer in the U.S. in 2024, consisting of 16,160 cases in men and 10,730 in women. This type of cancer is also expected to result in about 10,880 fatalities, involving 6,490 men and 4,390 women. Therefore, the growing occurrence of gastrointestinal disorders is propelling the constipation treatment market’s growth.

How Are Segments Identified Within The Constipation Treatment Market Segment Framework?

The constipation treatment market covered in this report is segmented –

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Therapeutics

2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

2) By Chloride Channel Activators: Lubiprostone-Based Formulations, Other Chloride Channel Activators

3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone Formulations, Naloxegol Formulations, Other PAMORAs

4) By Guanylate Cyclase-C (GC-C) Agonists: Linaclotide Formulations, Plecanatide Formulations, Other GC-C Agonists

5) By Other Therapeutics: Prokinetic Agents, Serotonin 5-HT4 Receptor Agonists, Herbal and Alternative Formulations

Which Trends Are Guiding The Direction Of The Constipation Treatment Market?

Major companies operating in the constipation treatment market are prioritizing the development of innovative solutions, such as drug-free mechanical stimulation capsules (vibrating capsules), to meet the rising demand for effective, side-effect-sparing therapies. This demand is propelled by an aging population, increased opioid use, and patients’ inclination towards non-pharmacologic choices. A vibrating capsule represents a swallowable, single-use oral device, encompassing a small vibration motor and battery within a medical-grade, excretable shell; its purpose is to mechanically stimulate the colon at programmed times to induce peristalsis, thereby offering predictable bowel movements without the systemic effects associated with laxatives or prescription prokinetics. As an illustration, in May 2023, Vibrant Ltd., a US-based medical technology company, launched Vibrant, a prescription-only vibrating capsule system that received clearance from the U.S. Food and Drug Administration (FDA) for adults with chronic idiopathic constipation who have not responded to laxatives. The system comprises a reusable activation pod and a single-use capsule containing a coin-sized vibration motor, an electronic control card, and batteries, all encased in a two-piece shell. The pod programs the capsule, which subsequently delivers a sequence of short vibration cycles, approximately 190 cycles per hour, featuring timed bursts and rests, specifically engineered to stimulate colonic contractions.

Who Are The Companies Competing Within The Constipation Treatment Market?

Major companies operating in the constipation treatment market are Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, Allergan plc

Get The Full Constipation Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Where Is The Constipation Treatment Market Primarily Concentrated By Region?

North America was the largest region in the constipation treatment market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Constipation Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Browse Through More Reports Similar to the Global Constipation Treatment Market 2026, By The Business Research Company

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Constipation Laxative Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-laxative-global-market-report

Opioid Induced Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-induced-constipation-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Constipation Treatment Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The constipation treatment market size has experienced strong growth in recent years. It is projected to increase from $12.71 billion in 2025 to $13.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This growth in the historic period can be linked to the high prevalence of gastrointestinal disorders, sedentary lifestyle patterns, dietary fiber deficiency, reliance on traditional laxatives, and aging population growth.

The constipation treatment market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $18.72 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.0%. This projected growth during the forecast period is fueled by several factors, including an increase in chronic constipation diagnoses, greater opioid consumption, heightened public understanding of gut health, the expansion of specialized gastroenterology services, and enhanced availability of innovative treatments. Key trends anticipated for this period encompass the increased application of prescription medications for long-term constipation, the wider acceptance of probiotics and digestive health products, a move towards drugs with specific mechanisms of action, an intensified focus on managing constipation linked to opioid use, and the broadening reach of online pharmacy channels.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12134&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Constipation Treatment Market?

The rising occurrence of gastrointestinal conditions is anticipated to fuel the expansion of the constipation treatment market in the coming years. Gastrointestinal disorders, also known as digestive disorders, refer to diverse health issues impacting the digestive tract, with constipation often presenting as a symptom. The increasing spread of these disorders, including conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), actively drives the constipation treatment market’s growth, as these conditions are frequently linked with constipation, thereby generating a greater demand for specialized and effective treatments amidst increasing public awareness. For instance, in January 2024, the American Cancer Society, a US-based non-profit organization, estimated approximately 26,890 new cases of stomach cancer in the U.S. for 2024, with 16,160 cases in men and 10,730 in women. This type of cancer is also projected to cause about 10,880 deaths, involving 6,490 men and 4,390 women. Consequently, the growing incidence of gastrointestinal disorders is a significant factor in boosting the constipation treatment market.

What Major Segment Divisions Exist Within The Constipation Treatment Market?

The constipation treatment market covered in this report is segmented –

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Therapeutics

2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

2) By Chloride Channel Activators: Lubiprostone-Based Formulations, Other Chloride Channel Activators

3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone Formulations, Naloxegol Formulations, Other PAMORAs

4) By Guanylate Cyclase-C (GC-C) Agonists: Linaclotide Formulations, Plecanatide Formulations, Other GC-C Agonists

5) By Other Therapeutics: Prokinetic Agents, Serotonin 5-HT4 Receptor Agonists, Herbal and Alternative Formulations

What Trends Are Projected To Affect The Constipation Treatment Market?

Leading companies in the constipation treatment market are concentrating on developing novel solutions, such as drug-free mechanical stimulation capsules (vibrating capsules). This focus aims to address the increasing demand for effective therapies with minimal side effects, a need driven by an aging population, greater opioid usage, and patient preference for non-pharmacologic alternatives. A vibrating capsule is a swallowable, single-use oral device containing a small vibration motor and a battery encased in a medical-grade, excretable shell. It is engineered to mechanically stimulate the colon at programmed times to induce peristalsis, providing predictable bowel movements without the systemic effects of laxatives or prescription prokinetics. For example, in May 2023, Vibrant Ltd., a US-based medical technology company, launched Vibrant, a prescription-only vibrating capsule system cleared by the U.S. Food and Drug Administration (FDA) for adults with chronic idiopathic constipation who have not responded to laxatives. The system includes a reusable activation pod and a single-use capsule, which houses a coin-sized vibration motor, an electronic control card, and batteries, all enclosed in a two-piece shell. The pod programs the capsule, which then delivers a series of short vibration cycles, approximately 190 cycles per hour with timed bursts and rests, specifically designed to stimulate colonic contractions.

Which Companies Are Leading Innovation In The Constipation Treatment Market?

Major companies operating in the constipation treatment market are Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, Allergan plc

Read the full constipation treatment market report here:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

What Are The Leading Geographic Regions In The Constipation Treatment Market?

North America was the largest region in the constipation treatment market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Constipation Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12134&type=smp

Browse Through More Reports Similar to the Global Constipation Treatment Market 2026, By The Business Research Company

Connected Health And Wellness Solutions Global Market Report

https://www.thebusinessresearchcompany.com/report/connected-health-and-wellness-solutions-global-market-report

Healthcare Services Market

https://www.thebusinessresearchcompany.com/report/healthcare-services-market

Healthcare Services Market

https://www.thebusinessresearchcompany.com/report/healthcare-services-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model